Twist Bioscience director Robert Chess sold $181,696 worth of stock via Investing.com

Robert Chess, a director at Twist Bioscience Corp (NASDAQ:), a biotechnology company with a capitalization of $2.82 billion, recently sold shares of the company, according to a regulatory filing. According to InvestingPro data, TWST has shown strong momentum with a…